Insights Into the Mechanisms of Brain Endothelial Erythrophagocytosis

Authors

Jiahong Sun, Keck Graduate Institute
Prema Vyas, Keck Graduate Institute
Samar Mann, Pitzer College
Annlia Paganini-Hill, University of California, Irvine
Ane C. F. Nunes, University of California, Irvine
Wei Ling Lau, University of California, Irvine School of Law
David H. Cribbs, University of California, Irvine
Mark J. Fisher, University of California, IrvineFollow
Rachita K. Sumbria, Chapman UniversityFollow

Document Type

Article

Publication Date

8-2-2021

Abstract

The endothelial cells which form the inner cellular lining of the vasculature can act as non-professional phagocytes to ingest and remove emboli and aged/injured red blood cells (RBCs) from circulation. We previously demonstrated an erythrophagocytic phenotype of the brain endothelium for oxidatively stressed RBCs with subsequent migration of iron-rich RBCs and RBC degradation products across the brain endothelium in vivo and in vitro, in the absence of brain endothelium disruption. However, the mechanisms contributing to brain endothelial erythrophagocytosis are not well defined, and herein we elucidate the cellular mechanisms underlying brain endothelial erythrophagocytosis. Murine brain microvascular endothelial cells (bEnd.3 cells) were incubated with tert-butyl hydroperoxide (tBHP, oxidative stressor to induce RBC aging in vitro)- or PBS (control)-treated mouse RBCs. tBHP increased the reactive oxygen species (ROS) formation and phosphatidylserine exposure in RBCs, which were associated with robust brain endothelial erythrophagocytosis. TNFα treatment potentiated the brain endothelial erythrophagocytosis of tBHP-RBCs in vitro. Brain endothelial erythrophagocytosis was significantly reduced by RBC phosphatidylserine cloaking with annexin-V and with RBC-ROS and phosphatidylserine reduction with vitamin C. Brain endothelial erythrophagocytosis did not alter the bEnd.3 viability, and tBHP-RBCs were localized with early and late endosomes. Brain endothelial erythrophagocytosis increased the bEnd.3 total iron pool, abluminal iron levels without causing brain endothelial monolayer disruption, and ferroportin levels. In vivo, intravenous tBHP-RBC injection in aged (17–18 months old) male C57BL/6 mice significantly increased the Prussian blue-positive iron-rich lesion load compared with PBS-RBC-injected mice. In conclusion, RBC phosphatidylserine exposure and ROS are key mediators of brain endothelial erythrophagocytosis, a process which is associated with increased abluminal iron in vitro. tBHP-RBCs result in Prussian blue-positive iron-rich lesions in vivo. Brain endothelial erythrophagocytosis may provide a new route for RBC/RBC degradation product entry into the brain to produce iron-rich cerebral microhemorrhage-like lesions.

Comments

This article was originally published in Frontiers in Cell and Developmental Biology, volume 9, in 2021. https://doi.org/10.3389/fcell.2021.672009

Recommended Citation

Sun J, Vyas P, Mann S, et al. Insights into the mechanisms of brain endothelial erythrophagocytosis. Front. Cell Dev. Biol. 2021;9:672009. https://doi.org/10.3389/fcell.2021.672009

Copyright

The authors

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.